Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 380 participants.

Also called NCT05765175

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 380 participants (planned count) (from the registry)
Sponsor
Varian, a Siemens Healthineers Company (from the registry)
Registry
  • NCT NCT05765175
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05765175. Randomized; no masking; primary purpose treatment. Start 2023-04-21 (actual); primary completion 2028-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
Acronym
RADIATE-VT
Condition
Tachycardia, Ventricular
Intervention (Device)
Varian Cardiac Radioablation (CRA)
Intervention (Procedure)
Catheter Ablation (CA)
Lead sponsor
Varian, a Siemens Healthineers Company (class: industry)

Record details

Record id
cardio:ct-nct05765175
Content hash
d7344501d4492f7b2e3072b9d8f784e3e123eaabe021ffcd45f3d8cbd056fcd5